Skip to content

Phibro Animal Health PAHC Operating Income

Operating Income at other companies

Neogen logo
NeogenNEOG
-$3.3M-161%
Balchem logo
BalchemBCPC
$55.63M+9.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$789.47M-5,100%
Cardinal Health logo
Cardinal HealthCAH
$509M-30.3%
Amgen logo
AmgenAMGN
$2.67B+126%
AbbVie logo
AbbVieABBV
$3.99B+6.9%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's operating income?
Phibro Animal Health (PAHC) reported operating income of $44.65M in Q1 2026.
How has Phibro Animal Health's operating income changed year-over-year?
Phibro Animal Health's operating income increased by 33.2% year-over-year, from $33.52M to $44.65M.
What is the long-term trend for Phibro Animal Health's operating income?
Over 4 years (2021 to 2025), Phibro Animal Health's operating income has grown at a 10.2% compound annual growth rate (CAGR), from $74.87M to $110.47M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.